GlobeNewswire by notified

MedAire Leads the Way in Enhanced Aviation Mental Health Support with MedAire Wellbeing Services Powered by Talk to a Peer

Share

Phoenix, Arizona, May 01, 2024 (GLOBE NEWSWIRE) -- May 1, 2024 – MedAire, the foremost provider of aviation medical and security services, is excited to announce the introduction of MedAire Wellbeing Services in a pioneering collaboration with OdiliaClark, leaders in impairment risk management and workplace wellbeing. This initiative sets a new standard for peer support within the business aviation sphere, offering a targeted approach to mental health and wellbeing tailored for aviation professionals.

The FAA Mental Health & Aviation Medical Clearances Aviation Rulemaking Committee's (ARC) recent deliberations on mental health in aviation highlighted the critical need for peer support enhancements beyond traditional Employee Assistance Programs (EAPs). Aligning with this foresight, MedAire Wellbeing Services offers a sophisticated peer support system tailored to the distinct needs of aviation crews.

"MedAire has been the go-to resource for aviation professionals, ensuring their health and safety for decades. We appreciate that an effective support system like our Wellbeing Services is vital to strengthening your safety culture. In partnership, we're cultivating a supportive community, making certain that each voice is heard, each person is assisted, and each member is valued." said Bill Dolny, CEO of MedAire

MedAire Wellbeing Services, leveraging the Talk to a Peer methodology, is designed to meet aviation crews' unique challenges. By harnessing digital health advancements, the service connects individuals with Peer Support Volunteers (PSVs)—current or former aviation professionals trained in best-in-class training that includes empathy, active listening, and resilience-building. This service promises an understanding and relevant support system, crucial for accessible and reliable mental health assistance.

Using a secure and confidential platform, MedAire Wellbeing Services ensures that aviation personnel can find support 24/7 anywhere in the world, matching them with peers or professionals who share their experiences. This system is built on camaraderie and a foundation of specialised training, safeguarding PSVs from secondary trauma and ensuring a robust support network.

"With MedAire Wellbeing Services, we've positioned our resources at the frontline of the industry's evolving approach to mental health," asserts Richard Gomez, VP of Aviation Products at MedAire. "Our initiative is supported by the FAA ARC's recommendations by bridging the gap between recognising mental health issues and actively addressing them, allowing aviation professionals to operate securely and confidently anywhere in the world."

Adding MedAire Wellbeing Services into MedAire's existing offerings represents a holistic approach to health, aligning physical and mental wellness strategies to the operational tempo of the aviation industry. This integrated support system allows MedAire to anticipate and respond to the evolving wellness needs of the aviation community, fostering a resilient and safe workforce.

"Our collaboration embodies an unmatched level of empathy and understanding within the aviation sector, combining our expertise to offer peer support that's both effective and compassionate," stated Peter Whitten, Sales Director at OdiliaClark. "This initiative reinforces the importance of mental health in maintaining safety and peak performance in aviation."

The global aviation community will get its first look at MedAire Wellbeing Services at EBACE 2024 in Geneva, Switzerland, where MedAire and OdiliaClark will showcase how this innovative service can bolster safety protocols and wellbeing strategies in stand Q68.

About MedAire: MedAire, an International SOS company, is the global leader in aviation and maritime health and safety solutions, with over three and a half decades of expertise committed to ensuring the wellbeing of crew and passengers alike. Providing an unparalleled suite of integrated medical, security, and operational services, MedAire is essential for those who operate in remote environments or require immediate assistance worldwide. Renowned for pioneering some of the industry's most advanced and responsive safety solutions, MedAire is the trusted partner for air and sea operators, from commercial airlines to private yachts. With services including 24/7 access to emergency medical assistance, state-of-the-art telemedicine, in-flight advice, and comprehensive medical training, they ensure that clients are prepared to manage any medical event anytime, anywhere. Their expertly curated health and security risk mitigation strategies and resources make safety and preparedness a seamless aspect of travel. MedAire continues to lead with innovative products, deep industry knowledge, and a passion for member care.

About OdiliaClark: OdiliaClark is a premier provider of mental health support, offering specialised services tailored to safety-critical industries, including aviation, oil & gas, energy, and manufacturing. Its flagship Peer Support Programme, "Talk To A Peer" (TTAP), is internationally recognised for enhancing workplace safety and wellbeing. This innovative programme helps create a culture of resilience by offering proactive, multi-organisational, collaborative support. Connecting employees with trained Peer Support Volunteers across partner organisations maximise engagement with and usage of the programme.

Its diverse team, comprised of experienced aviators, mental health professionals, and sector experts, promotes a healthy work environment. It is committed to improving safety, boosting productivity, and elevating overall wellbeing in every sector, making OdiliaClark a trusted partner in workplace mental health solutions globally.

###

For more information about MedAire or OdiliaClark or to schedule an interview, please contact:

For MedAire: Chris Potter, Head of Marketing, Aviation – chris.pottter@medaire.com

For OdiliaClark: Peter Whitten, Sales Director – peter.whitten@odiliaclark.com

-END-

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Subsea7 awarded a contract for the Belinda field in the UK North Sea25.5.2024 14:01:09 CEST | Press release

Luxembourg – 25 May 2024 - Subsea7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced the award of a sizeable1 contract by Serica Energy, for the Belinda field development south-east of the Triton FPSO. The Belinda field is operated by Serica Energy and located approximately 190 kilometres east of Aberdeen in the UK Central North Sea, with a water depth of 95 metres. The contract scope includes project management, engineering, procurement, construction and installation (EPCI) of a 5-kilometre 8” production pipeline with a 3” piggy-backed gas lift line and an electro-hydraulic controls (EHC) umbilical. Subsea7’s scope also includes associated subsea structures and tie-ins to the Triton Floating Production Storage & Offloading (FPSO) vessel operated by Dana Petroleum, via an existing production manifold near the Triton riser base and for controls at the Evelyn valve skid. Project management and engineering work will commence immediately in Aberdeen. The offshore activities are scheduled

Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio25.5.2024 12:15:00 CEST | Press release

In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor,demonstrated a statistically significant 36.1% proteinuria (protein in urine) reduction vs. placebo + supportive care at 36 weeks1 Endothelin A (ETA) receptor activation contributes to elevated proteinuria in IgAN2-5; atrasentan is a potent, selective ETA receptor antagonist with potential to reduce persistent proteinuria and preserve kidney function for a broad patient population1 IgAN is a heterogeneous, progressive, rare kidney disease with a need for effective, targeted therapies6,7; up to 30% of patients with persistent proteinuria (≥1 g/day) progress to kidney failure within 10 years8 Through its rare kidney disease portfolio, Novartis is committed to exploring a range of treatment options with different modes of action to slow IgAN progression Basel, May 25, 2024 – Novartis today presented results from a pre-specified interim analysis of the Phase III ALIGN study of atr

Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo25.5.2024 12:00:00 CEST | Press release

Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label data to be presented at a future medical meeting2,3Fabhalta showed a favorable safety profile with no new safety signals1C3G, an ultra-rare kidney disease caused by alternative complement pathway overactivation, progresses to kidney failure in ∼50% of patients within 10 years4-7; currently there are no treatments approved for C3G7-9 Fabhalta, an oral Factor B inhibitor of the alternative complement pathway, selectively targets the underlying cause of C3G1; late-stage development program ongoing across several other rare diseases10-13 Basel, May 25, 2024 – Novartis today presented results from the 6-month, double-blind period of the Phase III APPEAR-C3G study of Fabhalta® (iptacopan) at the late-breaking clinical trials session of the European Renal Association (ERA) Congress1. Patients treated with Fabhalta in addition to support

Metasphere Labs Announces Development of Innovative Carbon Credit Protocol for Grid-Scale Batteries24.5.2024 22:05:00 CEST | Press release

VANCOUVER, British Columbia, May 24, 2024 (GLOBE NEWSWIRE) -- Metasphere Labs Inc. (formerly Looking Glass Labs Ltd., "Metasphere" or the "Company") (Cboe Canada: LABZ) (OTC: LABZF) (FRA: H1N) is excited to announce an innovative initiative aimed at accelerating the decarbonization of the electricity grid through the development of a pioneering carbon credit protocol for grid-scale batteries. Innovative Carbon Credit Protocol The Company is committed to leveraging advanced technology to address critical environmental challenges. The new carbon credit protocol will enable grid-scale batteries to monetize their environmental attributes by generating carbon credits for the carbon reductions achieved through optimized battery operations. This protocol is designed to incentivize the deployment and operation of grid-scale batteries, ensuring they play a pivotal role in the transition to a clean energy future. Submission to Pure Sky Carbon Credit Registry The Company intends to submit this pr

Nokia Corporation: Repurchase of own shares on 24.05.202424.5.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 24 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 24.05.2024 Espoo, Finland – On 24 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL362,1533.55CEUX--BATE--AQEU--TQEX--Total362,1533.55 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of tra

HiddenA line styled icon from Orion Icon Library.Eye